Australia - English - Department of Health (Therapeutic Goods Administration)

st jude medical australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

st jude medical australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 35852 - defibrillator, implantable, automatic - the unify assura cd3361-40 is a cardiac resynchronisation therapy device with rf telemetry and it monitors and regulates the patient?s heart rate by providing ventricular tachyarrhythmia therapy and single site pacing. it features an is-1/df-1 device header. the unify assura cd3361-40 is intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. cardiac resynchronization therapy devices (crt-ds) are also intended to resynchronize the right and left ventricles in patients with congestive heart failure. also at/af detection algorithm is indicated for detecting atrial tachyarrhythmias which have been found to be associated with an increased risk of stroke in elderly, hypertensive, pacemaker patients without prior history of af.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 35852 - defibrillator, implantable, automatic - unify assura cd3361-40q is a cardiac resynchronisation therapy device with rf telemetry and it monitors and regulates the patient?s heart rate by providing ventricular tachyarrhythmia therapy and single site pacing. it features a df4 device header. the unify assura cd3361-40q is intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. cardiac resynchronization therapy devices (crt-ds) are also intended to resynchronize the right and left ventricles in patients with congestive heart failure. also at/af detection algorithm is indicated for detecting atrial tachyarrhythmias which have been found to be associated with an increased risk of stroke in elderly, hypertensive, pacemaker patients without prior history of af.

European Union - English - EMA (European Medicines Agency)

hra pharma rare diseases - mitotane - adrenal cortex neoplasms - antineoplastic agents - symptomatic treatment of advanced (unresectable, metastatic or relapsed) adrenal cortical carcinoma. the effect of lysodren on non-functional adrenal cortical carcinoma is not established.

Canada - English - Health Canada

apotex inc - nevirapine; zidovudine; lamivudine - tablet - 200mg; 300mg; 150mg - nevirapine 200mg; zidovudine 300mg; lamivudine 150mg - nonnucleoside reverse transcriptase inhibitors

Australia - English - Department of Health (Therapeutic Goods Administration)

universal pharmaceuticals pty ltd - squalene, quantity: 1000 mg - capsule, soft - excipient ingredients: soya oil; gelatin; d-alpha-tocopherol; purified water; glycerol - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; maintain/support skin health

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hra pharma uk ltd - mitotane - tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - tolterodine tartrate - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - tolterodine tartrate - oral tablet - 1mg